Shahryar Khan

Appearances

EVALUATION OF RISK OF BLEEDING IN COMPARISON OF DOACS VERSUS WARFARIN IN CONCOMITANT LIVER CIRRHOSIS AND ATRIAL FIBRILLATION - A SYSTEMATIC REVIEW AND META-ANALYSIS
Date
May 18, 2024
Over the last few years, the prevalence of atrial fibrillation (AF) has increased, and it is frequently diagnosed in cirrhotic patients. Current guidelines recommend anticoagulation in AF for prevention of stroke with CHA2DS2-VASc scores ≥2…
Presenter
Shahryar Khan
Speakers
Zeeshan Sattar
Yousaf Zafar
Farhan Sattar
Mashal Alam Khan
Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
Date
May 18, 2024
DEVELOPMENT AND VALIDATION OF THE HOPE-EVL SCORE: A SCORING SYSTEM FOR IN-HOSPITAL MORTALITY FOLLOWING BAND LIGATION IN ESOPHAGEAL VARICEAL BLEEDING
Moderators
Ashwani Singal
University of Alabama at Birmingham
Chien-Huan Chen
Washington University School of Medicine in St. Louis
Speakers
Chikamasa Ichita
Prooksa Ananchuensook
Gaurav B. Nigam
Anjali Byale
Shahryar Khan
Yanlin Lyu